3. Hemoglobin copy
Page 1: Anemia Definition
Anemia is defined as a deficiency of hemoglobin in the blood.
This deficiency can arise from two primary causes:
Too few RBCs (red blood cells)
Insufficient hemoglobin in the existing red blood cells
Page 2: Blood Loss Anemia
Blood Loss Anemia can occur after rapid hemorrhage:
The body compensates by replacing the plasma fluid within 1 to 3 days.
This quick response leads to a dilution of red blood cells, resulting in low RBC concentration.
If no further hemorrhage occurs, RBC concentration typically normalizes within 3 to 6 weeks.
Chronic blood loss can lead to:
Difficulty absorbing enough iron from the intestines.
Production of microcytic hypochromic anemia, characterized by smaller-than-normal RBCs with inadequate hemoglobin.
Page 3: Aplastic Anemia
Aplastic Anemia results from bone marrow dysfunction:
Condition defined as lack of functioning bone marrow.
Causes include:
High-dose radiation exposure.
Chemotherapy for cancer treatment.
Exposure to toxic chemicals (e.g., insecticides, benzene).
Autoimmune disorders (like lupus erythematosus) attacking healthy stem cells.
Approximately 50% of cases are idiopathic (unknown causes).
Treatment options:
Blood transfusions to temporarily increase RBC levels.
Bone marrow transplantation as a more permanent solution.
Page 4: Megaloblastic Anemia
Megaloblastic Anemia develops from the deficiency of vitamin B12, folic acid, and intrinsic factor:
This leads to slow erythroblast reproduction in the bone marrow.
Resulting RBCs are oversized and misshapen, known as megaloblasts.
Conditions causing this include:
Atrophy of stomach mucosa (e.g., pernicious anemia).
Total gastrectomy (removal of stomach).
Page 5: Impact of Nutrient Absorption
Megaloblastic anemia can also arise in patients with intestinal sprue:
In this condition, folic acid, vitamin B12, and other vitamin B compounds are poorly absorbed.
Erythroblasts cannot proliferate quickly enough, resulting in oversized and fragile RBCs.
These fragile cells rupture easily, leading to anemia severity.
Page 6: Hemolytic Anemia
Hemolytic Anemia is caused by RBC abnormalities:
Results in fragile cells that rupture easily in capillaries, particularly in the spleen.
RBC lifespan is shortened, causing serious anemia despite a normal or high RBC count in some diseases.
Hereditary Spherocytosis:
RBCs are spherical instead of biconcave.
They cannot withstand compression, leading to rupture in tight vascular areas.
Page 7: Sickle Cell Anemia
Sickle Cell Anemia is characterized by the abnormal hemoglobin type known as hemoglobin S:
Affects 0.3% to 1.0% of West African and American blacks.
Abnormal beta chains in hemoglobin cause the cells to form elongated crystals when oxygen levels are low.
Resulting in the sickle shape of RBCs instead of the normal biconcave disk.
Page 8: Crisis in Sickle Cell Disease
The abnormal hemoglobin leads to RBC membrane damage, increasing fragility:
This fragility can cause a sickle cell disease crisis, where low oxygen causes sickling leading to RBC rupture.
This cycle of sickling and destruction escalates rapidly and can be life-threatening.
Page 9: Erythroblastosis Fetalis
Erythroblastosis Fetalis involves Rh-positive RBCs of the fetus being attacked by antibodies from an Rh-negative mother:
This causes fragility and rapid rupturing of RBCs.
The fetus produces an excess of early blast forms of RBCs to compensate for cell destruction.
Page 10: Secondary Polycythemia
Secondary Polycythemia occurs in response to hypoxia:
Conditions like high altitude or cardiac failure stimulate an increase in RBC production.
Typically, the RBC count can rise to 6 to 7 million/mm3, roughly 30% above normal.
Physiological polycythemia is commonly seen in people living at high altitudes (14,000 to 17,000 feet).
Page 11: Polycythemia Vera
Polycythemia Vera (or Erythremia) is a pathological condition with an RBC count of 7 to 8 million/mm3 and a hematocrit of 60% to 70%:
Caused by a genetic mutation in blood cell production (hemocytoblastic cells).
The condition leads to unchecked RBC production despite existing cell levels.
Often results in overproduction of white blood cells and platelets.
Page 12: Consequences of Polycythemia Vera
In polycythemia vera, both hematocrit and total blood volume increase significantly:
Blood volume can nearly double.
The vascular system becomes engorged, with many capillaries potentially blocked due to thick blood.
Blood viscosity can increase from normal (3 times that of water) to 10 times.
Page 13: Erythropoietin Feedback Mechanism
The feedback circuit for erythropoietin responds to oxygen delivery levels:
A) For anemia (decreased erythrocyte mass), erythropoietin secretion increases and RBC production rises.
B) For hypoxia (lower arterial oxygen saturation), erythropoietin secretion similarly increases, promoting erythrocyte production.
C) In polycythemia vera (increased erythrocyte mass), erythropoietin production decreases.